A comfort survey of timolol hemihydrate 0.5% solution once or twice daily vs timolol maleate in sorbate

Journal of Current Glaucoma Practice

Volumn 7, Issue 1, 2013, Pages 11-16

  Stewart, William C ^a   Oehler, Jeffrey C ^b   Choplin, Neil T ^c   Markoff, Joseph I ^d   Moster, Marlene R ^e   Ichhpujani, Parul ^f   Nelson, Lindsay A ^a  

^a PRN Pharmaceutical Research Network LLC   (United States)

^b Northwest Eye Surgeons   (United States)

^c San Diego   (United States)

^d Will's Eye Philadelphia   (United States)

^e Ophthalmic Partners of Pennsylvania   (United States)

^f GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Betimol; Comfort; Glaucoma; Istalol; Timolol hemihydrate; Timolol maleate with potassium sorbate

Indexed keywords

ACETAZOLAMIDE; BIMATOPROST; BRINZOLAMIDE; LATANOPROST; SORBATE POTASSIUM; TIMOLOL; TIMOLOL MALEATE; TRAVOPROST;

ADULT; AGED; ARTICLE; EYE BURNING; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN ANGLE GLAUCOMA; PATIENT COMFORT; PRESCRIPTION; PROSPECTIVE STUDY; SIDE EFFECT; UNITED STATES;

EID: 84878379553     PISSN: 09740333     EISSN: 09751947     Source Type: Journal    
DOI: 10.5005/jp-journals-10008-1130     Document Type: Article

References (8)

1. Dubiner HB, Hill R, Kaufman H, Keates EU, Zimmerman TJ, Mandell AI, et al. TH vs timolol maleate to treat ocular hypertension and open-angle glaucoma. Am J Ophthalmol 1996;121:522-28.
2. Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocul Pharmacol Ther 1998;14:129-35.
3. Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. Am J Ophthalmol 1999;128:692-96.
4. Mundorf TK, Ogawa T, Inui N, Naka H, Novack GD, Crockett RS. Timolol LA: A double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteers. Curr Med Res Opin 2005;21:369-74.
5. Mundorf TK, Ogawa T, Naka H, Novack GD, Crockett RS. A 12-month, multicenter, randomized, double-masked, parallelgroup comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension. Clin Ther 2004;26:541-51.
6. Book SA. Essentials of Statistics. New York: McGraw-Hill, Inc. 1978.
7. Stewart WC, Stewart JA, Holmes KT, Leech JN. Differences in ocular surface irritation between timolol hemihydrate and timolol maleate. Am J Ophthalmol 2000;130(6):712-16.
8. Sonty S, Mundorf TK, Stewart JA, Stewart WC. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, three-period crossover pilot study. Clin Ther 2009;31(10): 2063-71.